Healthy volunteers with cold sensitivity
Conditions
Interventions
NKCP 250 mg/day for 4 weeks A washout period for 4 weeks
Placebo for 4 weeks A washout period for 4 weeks
Sponsors
Laboratory of Cell Applied Technologies, Co
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females aged 30-70 years 2) Individuals who are cold sensitivity 3) Individuals whose written informed consent has been obtained 4) Individuals judged appropriate for the study by the principal
Exclusion criteria
Exclusion criteria: 1) Individuals who receives a drug influencing blood coagulation system 2) Individuals who has a cardiovascular disease, the cerebro-vascular disease past or under treatment 3) Individuals who has a diagnosis of intractable peripheral circulatory disease such as Raynaud's disease 4) Individuals who has a disease judged to affect the examination results 5) Individuals who are sensitive to a food containing test product or other foods, and medical products 6) Individuals who have a habit of smoking 7) Individuals that the change of the lifestyle is planned during a study time (a night-work, a long-term trip, the transfer) 8) Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period 9) Individuals who participated in other clinical studies in the past three months 10) Individuals who are or are possibly pregnant, or are lactating 11) etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bloodstream, pulsation (Week 0, Week 4, Week 8) | — |
Countries
Japan
Contacts
Public ContactMasanori Inoue
Laboratory of Cell Applied Technologies, Co Director
Outcome results
None listed